医学
血糖性
糖尿病
糖化血红素
糖尿病管理
重症监护医学
低血糖
1型糖尿病
胰岛素
2型糖尿病
糖尿病酮症酸中毒
血糖自我监测
连续血糖监测
内科学
内分泌学
作者
Alice P.S. Kong,Soo Lim,Seung-Hyun Yoo,Linong Ji,Liming Chen,Yuqian Bao,Ester Yeoh,Siew-Pheng Chan,Chih‐Yuan Wang,Viswanathan Mohan,Neale Cohen,Margaret McGill,Stephen M. Twigg
标识
DOI:10.1016/j.diabres.2023.110718
摘要
Glucose monitoring has evolved from self-monitoring of blood glucose to glycated hemoglobin, and the latest continuous glucose monitoring (CGM). A key challenge to adoption of CGM for management of diabetes in Asia is the lack of regional CGM recommendations. Hence, thirteen diabetes-specialists from eight Asia-Pacific (APAC) countries/regions convened to formulate evidence-based, APAC-specific CGM recommendations for individuals with diabetes. We defined CGM metrics/targets and developed 13 guiding-statements on use of CGM in: (1) people with diabetes on intensive insulin therapy, and (2) people with type 2 diabetes on basal insulin with/without glucose lowering drugs. Continual use of CGM is recommended in individuals with diabetes on intensive insulin therapy and suboptimal glycemic control, or at high risk of problematic hypoglycemia. Continual/intermittent CGM may also be considered in individuals with type 2 diabetes on basal insulin regimen and with suboptimal glycemic control. In this paper, we provided guidance for optimizing CGM in special populations/situations, including elderly, pregnancy, Ramadan-fasting, newly diagnosed type 1 diabetes, and comorbid renal disease. Statements on remote CGM, and stepwise interpretation of CGM data were also developed. Two Delphi surveys were conducted to rate the agreement on statements. The current APAC-specific CGM recommendations provide useful guidance for optimizing use of CGM in the region.
科研通智能强力驱动
Strongly Powered by AbleSci AI